Tag: Environmental monitoring

Microbiology in Stability Studies: Requirements for Different Dosage Forms Microbiology in Stability Studies: Essential Requirements for Different Dosage Forms Pharmaceutical stability studies are a critical component in ensuring drug product safety, efficacy, and quality throughout its shelf life. A paramount element of these studies involves the role of microbiology, particularly when addressing sterility assurance, microbial…

Read More “Microbiology in Stability Studies: Requirements for Different Dosage Forms” »

Microbiology in Stability Studies: Requirements for Different Dosage Forms Microbiology in Stability Studies: Ensuring Compliance Across Dosage Forms Pharmaceutical stability studies are a critical component in confirming the quality, safety, and efficacy of drug products throughout their shelf life. Integral to these studies is the role of microbiology, especially when dealing with sterile and non-sterile…

Read More “Microbiology in Stability Studies: Requirements for Different Dosage Forms” »

Microbiology Considerations in ATMP Manufacturing: Closed vs Open Systems Microbiology Considerations in ATMP Manufacturing: Closed Versus Open Systems Advanced Therapy Medicinal Products (ATMPs) represent a paradigm shift in pharmaceutical therapeutics, incorporating gene therapies, somatic cell therapies, and tissue-engineered products. The sterility assurance and microbiological control in ATMP manufacturing are paramount due to the highly sensitive…

Read More “Microbiology Considerations in ATMP Manufacturing: Closed vs Open Systems” »

Mycoplasma Control in Biologics Production: Testing and Risk Mitigation Comprehensive Step-by-Step Guide for Mycoplasma Control in Biologics Production Mycoplasma contamination poses a significant risk to the sterility assurance and overall quality of biologics manufacturing. These fastidious microorganisms can evade conventional bacterial detection methods and have the potential to compromise both product safety and efficacy. This…

Read More “Mycoplasma Control in Biologics Production: Testing and Risk Mitigation” »

Viral Safety in Biologics: Inactivation, Removal and Validation Viral Safety in Biologics: Ensuring Inactivation, Removal, and Validation Ensuring viral safety in biologics is a paramount concern for pharmaceutical manufacturers operating under stringent regulatory frameworks in the US, UK, and EU. Robust strategies focusing on sterility assurance, pharma microbiology, and validated water systems are essential to…

Read More “Viral Safety in Biologics: Inactivation, Removal and Validation” »

Microbiology and PAT: Real-Time Monitoring Technologies and Their Limits Microbiology and PAT: Advances and Constraints in Real-Time Monitoring Technologies In pharmaceutical manufacturing, sterility assurance and stringent control over microbial contamination represent critical quality attributes. The integration of Process Analytical Technology (PAT) into pharma microbiology workflows has accelerated the move toward real-time monitoring, offering significant advantages…

Read More “Microbiology and PAT: Real-Time Monitoring Technologies and Their Limits” »

Using Simulation Studies to Validate Microbial Control in Complex Lines Simulation Studies for Validation of Microbial Control in Complex Pharmaceutical Utility Lines Ensuring sterility assurance and microbial control is a fundamental requirement in pharmaceutical manufacturing, particularly when dealing with complex lines involving Purified Water (PW), Water for Injection (WFI), clean steam, and other critical GMP…

Read More “Using Simulation Studies to Validate Microbial Control in Complex Lines” »

Implementation of ATP and Fluorescence-Based Environmental Monitoring Step-by-Step Guide to Implementing ATP and Fluorescence-Based Environmental Monitoring in Pharmaceutical Manufacturing Ensuring sterility assurance remains a cornerstone of pharmaceutical manufacturing and quality control, particularly in sterile product environments. The integration of advanced technologies such as Adenosine Triphosphate (ATP) and fluorescence-based environmental monitoring techniques into pharma microbiology programs…

Read More “Implementation of ATP and Fluorescence-Based Environmental Monitoring” »

Viable but Non-Culturable (VBNC) Microorganisms: Relevance for Pharma Understanding Viable but Non-Culturable (VBNC) Microorganisms: Essential Guidance for Pharma Sterility Assurance Pharmaceutical bioprocesses and sterile manufacturing operations increasingly acknowledge the risks posed by viable but non-culturable (VBNC) microorganisms. These microbes challenge conventional microbiological methods, as they remain metabolically active yet resist growth on standard culture media….

Read More “Viable but Non-Culturable (VBNC) Microorganisms: Relevance for Pharma” »

Microbiological Risk Assessment for New Facilities and Processes Step-by-Step Guide: Microbiological Risk Assessment for New Pharma Facilities and Processes Establishing a new pharmaceutical manufacturing facility or introducing new processes demands rigorous microbiological risk assessment to ensure robust sterility assurance and compliance with global Good Manufacturing Practice (GMP) requirements. With complex interactions among pharma microbiology factors,…

Read More “Microbiological Risk Assessment for New Facilities and Processes” »